WHAT WE DO
Our expert team of analysts and consultants are based across three continents, Europe, North America and Asia, with our head office in Cambridge, UK. Our global team is able to utilise their local area knowledge, expertise and languages, with more than fifteen spoken between them. Our shared experience allows us to help you confidently navigate the evolving healthcare market and competitive landscape.
Our primary mission is to enable our clients to navigate difficult commercial decisions by helping map their position in a complex marketplace, providing a deep understanding of their environment, high impact trends and dynamics, as well as outlining competitor activities, intent and capabilities.
We deliver tailored strategy solutions based on our analysis and experience of strategy consulting and product commercialisation in the pharmaceutical, biotechnology, medical device, and life-science sectors.
We achieve this by delivering tailored strategy solutions, market and competitor analysis. Our work is based on experience across therapeutic areas and healthcare settings as well as exposure to product commercialisation in the pharmaceutical, biotechnology, medical device, and life-science sectors.
WHO WE ARE
We are passionate about healthcare and medical innovation. CHR provides strategic decision support and action planning to a wide range of stakeholders across the healthcare industry.
At CHR, our evidence-based recommendations are built on robust and transparent analysis.
The team combine their collective experience of the sector to the strategy consulting tool-set, where generated hypotheses are subjected to iterative rounds of research and validation.
Our evaluation of market dynamics, combined with a targeted understanding of key trends in the prescriber, regulator, and payer environments, equips our clients to make the best decisions from an optimally informed position.
Cambridge Healthcare Research is based at St. John’s Innovation Park, in the heart of Europe’s leading commercial pharmaceutical and biotechnology cluster.